Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency

Get in touch with RARE Concierge.

Contact RARE Concierge

Synonyms: Hyperinsulinemic hypoglycemia due to SUR1 deficiency, diazoxide-resistant focal form

A rare congenital isolated hyperinsulinism disorder characterized by diazoxide unresponsive recurrent episodes of hyperinsulinemic hypoglycemia resulting from an excessive insulin secretion by the pancreatic beta-cells due to a mutation in the ABCC8 gene. Pancreatic involvement is focal and can be cured by a selective partial pancreatectomy. Hypoglycemia may lead to variable clinical manifestations ranging from asymptomatic hypoglycemia revealed by routine blood glucose monitoring to macrosomia at birth mild to moderate hepatomegaly and life-threatening hypoglycemic coma or status epilepticus further leading to poor neurological outcome.

Data from Orphanet are used to provide information on a disease's name, synonym(s), and overview. Reference: Access aggregated data from Orphanet at Orphadata. Orphadata: Free access data from Orphanet. © INSERM 1999. Available on http://www.orphadata.org. Data version July 2024

Newly diagnosed with
Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency?

Our RARE Concierge Services Guides are available to assist you by providing information, resources and connections as you navigate your rare disease journey.

Get Concierge Help

Advocacy Organizations

Congenital Hyperinsulinism International

CHI is the leading organization dedicated to improving the lives of people with hyperinsulinism (HI). HI is a life-threatening disorder that causes dangerously low blood sugar levels due to the over-production of insulin. Prolonged or severe low blood sugar can cause seizures, brain damage, and even death. CHI supports research toward better treatments and a cure, tirelessly advocates for timely diagnosis and improved standards of care, and supports people living with HI every step of the way.

Don't see your organization here. Let us know here.

Clinical Trials

For a list of clinical trials in this disease area, please click here.